HomeCompareAMNC vs MRK

AMNC vs MRK: Dividend Comparison 2026

AMNC yields 166666.67% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMNC wins by $7.944525992890705e+28M in total portfolio value
10 years
AMNC
AMNC
● Live price
166666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.944525992890705e+28M
Annual income
$79,351,601,962,005,455,000,000,000,000,000,000.00
Full AMNC calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AMNC vs MRK

📍 AMNC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMNCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMNC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMNC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMNC
Annual income on $10K today (after 15% tax)
$14,166,666.67/yr
After 10yr DRIP, annual income (after tax)
$67,448,861,667,704,640,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AMNC beats the other by $67,448,861,667,704,640,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMNC + MRK for your $10,000?

AMNC: 50%MRK: 50%
100% MRK50/50100% AMNC
Portfolio after 10yr
$3.972262996445352e+28M
Annual income
$39,675,800,981,002,727,000,000,000,000,000,000.00/yr
Blended yield
99.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AMNC
No analyst data
Altman Z
0.0
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMNC buys
0
MRK buys
0
No recent congressional trades found for AMNC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMNCMRK
Forward yield166666.67%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$7.944525992890705e+28M$56.8K
Annual income after 10y$79,351,601,962,005,455,000,000,000,000,000,000.00$9,798.13
Total dividends collected$7.943912645651793e+28M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AMNC vs MRK ($10,000, DRIP)

YearAMNC PortfolioAMNC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$16,677,367$16,666,666.67$11,206$366.19+$16.67MAMNC
2$25,995,051,428$25,977,206,645.90$12,650$502.35+$25995.04MAMNC
3$37,869,622,473,147$37,841,807,768,118.86$14,407$694.19+$37869622.46MAMNC
4$51,562,007,868,526,340$51,521,487,372,480,070.00$16,585$967.82+$51562007868.51MAMNC
5$65,615,852,892,511,920,000$65,560,681,544,092,600,000.00$19,342$1,363.89+$65615852892511.91MAMNC
6$78,042,202,741,585,770,000,000$77,971,993,778,990,800,000,000.00$22,913$1,947.19+$78042202741585760.00MAMNC
7$86,754,863,367,545,780,000,000,000$86,671,358,210,612,300,000,000,000.00$27,662$2,823.89+$86754863367545782272.00MAMNC
8$90,137,108,986,090,100,000,000,000,000$90,044,281,282,286,820,000,000,000,000.00$34,159$4,173.35+$9.01371089860901e+22MAMNC
9$87,530,810,188,407,730,000,000,000,000,000$87,434,363,481,792,600,000,000,000,000,000.00$43,337$6,308.80+$8.753081018840772e+25MAMNC
10$79,445,259,928,907,045,000,000,000,000,000,000$79,351,601,962,005,455,000,000,000,000,000,000.00$56,776$9,798.13+$7.944525992890705e+28MAMNC

AMNC vs MRK: Complete Analysis 2026

AMNCStock

Amincor, Inc., through its subsidiaries, manufactures and sells bakery food products. It provides various sliced bread, yeast and cake doughnuts, frozen donuts, cookies, and snack products to supermarket "in-store" bakery departments, and food service channels. It also offers water remediation services, such as water testing and evaluation, system engineering and design, system training servicing, and maintenance service in the northeast United States, as well as is involved in treating and discharging petroleum impacted water into the sanitary sewer system. The company serves oil companies, petroleum marketers, jobbers, municipal entities, school districts, industrial facilities, and other businesses. In addition, it provides maintenance, repair, and construction services to customers with underground petroleum storage tanks and petroleum product dispensing equipment, as well as is engaged in environmental consulting, site assessment, analysis, and management of site remediation for owners and operators of petroleum storage facilities. The company serves national and multinational enterprises, as well as to local and national governmental agencies and municipalities. The company was formerly known as Joning Corp and changed its name to Amincor, Inc. in February 2010. Amincor, Inc. was incorporated in 1997 and is headquartered in New York, New York.

Full AMNC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AMNC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMNC vs SCHDAMNC vs JEPIAMNC vs OAMNC vs KOAMNC vs MAINAMNC vs JNJAMNC vs ABBVAMNC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.